Lotus Pharmaceutical Co., Ltd. (TPE:1795)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
220.50
-3.50 (-1.56%)
Apr 29, 2026, 1:30 PM CST
2.80%
Market Cap 58.87B
Revenue (ttm) 20.51B
Net Income (ttm) 4.72B
Shares Out 262.81M
EPS (ttm) 18.04
PE Ratio 12.42
Forward PE 13.89
Dividend 2.56 (1.16%)
Ex-Dividend Date Aug 11, 2025
Volume 1,839,015
Average Volume 2,691,394
Open 226.50
Previous Close 224.00
Day's Range 220.50 - 226.50
52-Week Range 185.00 - 369.50
Beta 0.52
RSI 45.04
Earnings Date May 7, 2026

About Lotus Pharmaceutical

Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, central nervous system, cardiovascular diseases, woman health, and anti-obesity. The company also engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business... [Read more]

Sector Healthcare
Founded 1966
Employees 1,099
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1795
Full Company Profile

Financial Performance

In 2025, Lotus Pharmaceutical's revenue was 20.51 billion, an increase of 10.36% compared to the previous year's 18.58 billion. Earnings were 4.72 billion, a decrease of -6.82%.

Financial Statements

News

There is no news available yet.